Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This example shows a sample report table, trial design, and results data dataset for Study #123 for the determination of the in vitro genotoxicity potential of tobacco products in using the in vitro Micronucleus Assay. This sample study 


Expand
titleSample Report Table for Study 123

Dataset wrap
Rowcaps
Rows 1-2:Show two records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP Types apply for this example study. 
Row 8:Shows that the sponsor's study reference ID is not applicable.
Rows 9-12:Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The Study Director is associated with the Test Facility.
Dataset2

Row

STUDYID

ASSAYID

DOMAIN

TSSEQ

TSGRPID

TSPARMCD

TSPARM

TSVAL

TSVALNF

1123NRUTS1
GLPTYPGood Laboratory Practice TypeFDA
2123NRUTS2
GLPTYPGood Laboratory Practice TypeOECD
3123NRUTS1
STSTDTCStudy Start Date2022-05-25
4123NRUTS1
STITLEStudy Title

Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay


5123NRUTS1
SNDIGVERSEND Implementation Guide VersionTOBACCO IMPLEMENTATION GUIDE VERSION 1.0
6123NRUTS1
SNDCTVERSEND Controlled Terminology VersionSEND Terminology 2021-09-30
7123NRUTS1
SSPONSORSponsor OrganizationExample Sponsor Inc.
8123NRUTS1
SPREFIDSponsor Study Reference ID
NOT APPLICABLE
9123NRUTS11TSTFNAMTest Facility NameExample Test Lab Name
10123NRUTS11TSTFLOCTest Facility Location10 Somewhere Street, Montgomery, AL 10000
11123NRUTS11TFCNTRYTest Facility CountryUSA
12123NRUTS11STDIRStudy DirectorDr. R. Smith
13123NRUTS1
GLPFLGLP FlagY
14123NRUTS1
ASTDAssay StandardNIH Publication OECD GUIDELINE FOR THE TESTING OF CHEMICALS No. 07-4519487
15123NRUTS1
ASTDVAssay Standard Version200629-July-112016
16123NRUTS1
SSTYPStudy TypeGENOTOXICITY IN VITRO
17123NRUTS1
SSSTYPStudy Sub TypeIn Vitro Neutral Red UptakeMICRONUCLEUS TEST 
18123NRUTS1
SPECIESSpeciesHamsterHUMAN
19123NRUTS1
TESTSYSTest SystemCHO

TK6 LYMPHOBLASTOID


This example trial set dataset, tx.xpt, shows information about the test conditions for set A1 and A2 in this example study, 123. Set A1 and A2 can be seen in the first and second rows respectively of Table 1 in the Sample Report table for Study 123 (above).  For brevity, the trial sets dataset, tx.xpt, and the findings dataset, gt.xpt do not show information for any other sets.  Fully formed datasets for this example study would include information about the test conditions and findings for all sets. 

Dataset wrap
Nametx.xpt
Rowcaps
Rows 1-23:

Show trial set parameters and trial set values that comprise the test conditions for trial set A1. Set A1 is the data for the negative control (concentration 0) with short term exposure and metabolic activation S9.  The applicant has chosen to given a long name (SET) equal to "ST+S9_C0".

Set A1 is associated with the first row in the sample report table for study 123.

Rows 24-46:

Show trial set parameters and trial set values that comprise the test conditions for trial set A2. Set A2 is the data for the short term exposure with metabolic activation S9 at a concentration of 1250 ug/ml.  The applicant has chosen to give the set a long name (SET) equal to "ST+S9_C1250".

Set A2 is associated with the second row in the sample report table for study 123.

Dataset2
RowSTUDYIDGNTXAIDDOMAINSETCDSETTXSEQTXPARMCDTXPARMTXVAL
1123MNvitTX

A1

ST+S9_C02METACTMetabolic Activation+S9
2123MNvitTXA1ST+S9_C03METACTFLY/N presence of metabolic activationY
3123MNvitTX

A1

ST+S9_C04TRTDMINTreatment Duration Minimum3
4123MNvitTXA1ST+S9_C05TRTDTRGTreatment Duration Target3.5
5123MNvitTXA1ST+S9_C06TRTDMAXTreatment Duration Maximum4
6123MNvitTX

A1

ST+S9_C07TRTDUTreatment Duration UnitHOURS
7123MNvitTXA1ST+S9_C08RCVDMINRecovery Duration Minimum23.5
8123MNvitTXA1ST+S9_C09RCVDTRGRecovery Duration Target24
9123MNvitTX

A1

ST+S9_C010RCVDMAXRecovery Duration Maximum24.5
10123MNvitTXA1ST+S9_C011RCVDURecovery Duration UnitHOURS
11123MNvitTXA1ST+S9_C012INCBTMPIncubation Temperature37
12123MNvitTX

A1

ST+S9_C013INCBTMPUIncubation Temperature UnitC
13123MNvitTXA1ST+S9_C014HUMIDAtmospheric Relative Humidity Percent50
14123MNvitTX

A1

ST+S9_C015ATMCO2Atmospheric CO2 Percent5
15123MNvitTXA1ST+S9_C016

SPTOBID

Sponsor defined tobacco identifier

CIG01a
16123MNvitTXA1ST+S9_C017EXPTYP

Exposure Type

Submerged
17123MNvitTXA1ST+S9_C018SAMTYP

Sample Type

Total Particulate Matter in DMSO
18123MNvitTXA1ST+S9_C019INTRVN

Name of the Intervention Article

Tobacco ProdA
19123MNvitTXA1ST+S9_C020ITVTYPE

type of intervention article

Negative Control
20123MNvitTXA1ST+S9_C021ITVCONCConcentration of intervention article0
21123MNvitTXA1ST+S9_C022ITVCONCUConcentration Unitug/ml
22123MNvitTXA1ST+S9_C023

SPDEVID

Sponsor defined device identifierPUFFMASTER3K
23123MNvitTXA1ST+S9_C024

DUREFID

Smoke RegimenMedium Intensity Regimen
24123MNvitTX

A2

ST+S9_C12502METACTMetabolic Activation+S9
25123MNvitTXA2ST+S9_C12503METACTFLY/N presence of metabolic activationY
26123MNvitTXA2ST+S9_C12504TRTDMINTreatment Duration Minimum3
27123MNvitTXA2ST+S9_C12505TRTDTRGTreatment Duration Target3.5
28123MNvitTXA2ST+S9_C12506TRTDMAXTreatment Duration Maximum4
29123MNvitTXA2ST+S9_C12507TRTDUTreatment Duration UnitHOURS
30123MNvitTXA2ST+S9_C12508RCVDMINRecovery Duration Minimum23.5
31123MNvitTXA2ST+S9_C12509RCVDTRGRecovery Duration Target24
32123MNvitTXA2ST+S9_C125010RCVDMAXRecovery Duration Maximum24.5
33123MNvitTXA2ST+S9_C125011RCVDURecovery Duration UnitHOURS
34123MNvitTXA2ST+S9_C125012INCBTMPIncubation Temperature37
35123MNvitTXA2ST+S9_C125013INCBTMPUIncubation Temperature UnitC
36123MNvitTXA2ST+S9_C125014HUMIDAtmospheric Relative Humidity  Percent50
37123MNvitTXA2ST+S9_C125015ATMCO2Atmospheric CO2 Percent5
38123MNvitTXA2ST+S9_C125016SPTOBID

Sponsor defined tobacco identifier

CIG01a
39123MNvitTXA2ST+S9_C125017EXPTYP

Exposure Type

Submerged
40123MNvitTXA2ST+S9_C125018SAMTYP

Sample Type

Total Particulate Matter in DMSO
41123MNvitTXA2ST+S9_C125019INTRVN

Name of the Intervention Article

Tobacco ProdA
42123MNvitTXA2ST+S9_C125020ITVTYPE

type of intervention article

Product
43123MNvitTXA2ST+S9_C125021ITVCONCConcentration of intervention article1250
44123MNvitTXA2ST+S9_C125022ITVCONCUConcentration Unitug/ml
45123MNvitTXA2ST+S9_C125023SPDEVIDSponsor defined device identifierPUFFMASTER2023
46123MNvitTXA2ST+S9_C125024DUREFIDSmoke RegimenHigh Intensity Regimen
Dataset wrap
Namerelref.xpt
Rowcaps
Row 1:Shows the value of REFID=C0, . This REFID refers to the trial set with a SETCD of 'A1', as defined in the trial set dataset, tx.xpt.  LEVEL=1 and LVLDESC='EXPERIMENTAL UNIT/TRIAL SET' indicates this identifier relates is referring to the entire trial setboth the experimental unit, the unit to which the treatment is applied, and the entire trial set.
Rows 2-5:Show the values of four observational units C0_Count1 through C0_Count4 that are within the parent experimental unit, REFID=C0, and in this example assay these observational units are also all within the same trial set, as defined in the trial set dataset, tx.xpt.
Rows 6:Shows the value ...of REFID=C1250. This REFID refers to the trial set with a SETCD of 'A2', as defined in the trial set dataset, tx.xpt.  LEVEL=1 and LVLDESC='EXPERIMENTAL UNIT/TRIAL SET' indicates this identifier is referring to both the experimental unit, the unit to which the treatment is applied, and the entire trial set.
Row 7-10:Show the values of four observational units C1250_Count1 through C1250_Count4 that are within the parent experimental unit, REFID=C0, and in this example assay these observational units are also all within the same trial set, as defined in the trial set dataset, tx.xpt.Row 7-10:Show the values of four 
Dataset2
tableidrelref.xpt
10

Row

STUDYID

GNTXAID

SETCD

REFID

PARENT

LEVEL

LVLDESC

1

123

MNvit

A1

C0
1

EXPERIMENTAL UNIT/TRIAL SET

2

123

MNvit

A1

C0-Count1C02OBSERVATIONAL UNIT

3

123

MNvit

A1

C0-Count2C02OBSERVATIONAL UNIT

4

123

MNvit

A1

C0-Count3C02OBSERVATIONAL UNIT

5

123

MNvit

A1

C0-Count4C02OBSERVATIONAL UNIT
C0

6

123

MNvit

A2C12501EXPERIMENTAL UNIT/TRIAL SET7123

MNvit

A2C1250-Count1C12502OBSERVATIONAL UNIT8

5

123

MNvit

A2

A1

C1250C0-Count2Count4C1250C02OBSERVATIONAL UNIT9

6

123

MNvit

A2C1250-Count3C1250
21OBSERVATIONAL EXPERIMENTAL UNIT/TRIAL SET
7123

MNvit

A2C1250-Count4C12502OBSERVATIONAL UNIT

A1: Image Removed

A2:                                   Image Removed

1
Count1C12502OBSERVATIONAL UNIT
8123

MNvit

A2C1250-Count2C12502OBSERVATIONAL UNIT
9
Expand
titleou.xpt
RowSTUDYIDASSAYIDDOMAINSETCD EUIDOBUID
123

MNvit

EI
A2
A1
C1250-Count3
C0
C12502OBSERVATIONAL UNIT
10123

MNvit

EIA2C1250

A2C1250-Count4C12502OBSERVATIONAL UNIT


A1: Image Added


A2:                                   Image Added




Dataset wrap
Namegt.xpt
Rowcaps
Rows 1-5:Show the number of revertant colonies per plate collected for each of five observational units ( REFID=0_1 through 0_5 as described in the relref dataset).
Rows 6, 7:Show summary values collected (MEAN, STANDARD DEVIATION) for REFID=A that apply to the entire trial set, SetA, as indicated by LEVEL=1 and LVLDESC=TRIAL SET for this REFID in the relref dataset. 
Rows 8-13: Revertent colonies were counted for each of three plates/observational units (REFID=6_1 through 6_3) and each value is associated with a record to show a postfix code of "V" = "Very thin background bacterial lawn"
Rows 14-16:Show summary values collected (MEAN, STANDARD DEVIATION, and FOLD INCREASE) for REFID=F that apply to the entire trial set, SetF, as indicated by LEVEL=1 and LVLDESC=TRIAL SET for this REFID in the relref dataset. 
Rows 17-19:Show three plates/observational units (REFID=5_1 through 5_3) where no revertant colonies were counted due to too much cytotoxicity and a postfix code of "T".
Rows 20-22:Show the number of revertant colonies per plate collected for each of three observational units (REFID=18_1 through 18_3 as described in the relref dataset).
Rows 23-25:Show summary values collected (MEAN, STANDARD DEVIATION, and FOLD INCREASE) for REFID=R that apply to the entire trial set, SetR, as indicated by LEVEL=1 and LVLDESC=TRIAL SET for this REFID in the relref dataset. 
Dataset2
RowSTUDYIDGNTXAIDDOMAIN
EUID

OBUID

REFID

GTSEQGTTESTCDGTTESTGTCELLEVGTORRESGTORRESU

GTCOLSRT

GTSTRESCGTSTRESNGTSTRESUGTDTC
1123MNvitGT
C0
C01RICCRelative Increase in Cell Count1540%
00%2022-05-25
2123MNvitGT
C0
C02RCCRelative Cell Count1540%
00%2022-05-25
3123MNvitGT
C0
C03RPDRelative Population Doubling1540%
00%2022-05-25
4123MNvitGT
C0
C0-Count14MNCELLSMicronucleated Cells220515Cells
1515Cells2022-05-25
5123MNvitGT
C0
C0-Count25MNCELLSMicronucleated Cells247413Cells
1313Cells2022-05-25
6123MNvitGTC0
C0
-Count36MNCELLSMicronucleated Cells275817Cells
1717Cells2022-05-25
7123MNvitGT
C0
C0-Count47MNCELLSMicronucleated Cells266912Cells
1212Cells2022-05-25
8123MNvitGTC0
C0
8AVGRELAverage Relative MN Frequency
0.57%
0.570.57%2022-05-25
9123MNvitGT
C1250
C12501RICCRelative Increase in Cell Count13415.7%
15.715.7%2022-05-25
10123MNvitGT
C1250
C12502RCCRelative Cell Count13413.0%
13.013.0%2022-05-25
11123MNvitGT
C1250
C12503RPDRelative Population Doubling1347.9%
7.97.9%2022-05-25
12123MNvitGT
C1250
C1250-Count14MNCELLSMicronucleated Cells326620Cells
2020Cells2022-05-25
13123MNvitGTC1250
C1250
-Count25MNCELLSMicronucleated Cells219017Cells
1717Cells2022-05-25
14123MNvitGT
C1250
C1250-Count36MNCELLSMicronucleated Cells275813Cells
1313Cells2022-05-25
15123MNvitGTC1250
C1250
-Count47MNCELLSMicronucleated Cells271421Cells
2121Cells2022-05-25
16123MNvitGT
C1250
C12508AVGRELAverage Relative MN Frequency
0.66%
0.660.66%2022-05-25